These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3840910)

  • 1. Overview of Chlamydia trachomatis infection and the requirements for a vaccine.
    Schachter J
    Rev Infect Dis; 1985; 7(6):713-6. PubMed ID: 3840910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    Badamchi-Zadeh A; McKay PF; Holland MJ; Paes W; Brzozowski A; Lacey C; Follmann F; Tregoning JS; Shattock RJ
    PLoS One; 2015; 10(10):e0141209. PubMed ID: 26501198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a Chlamydia trachomatis vaccine: how close are we?
    Cochrane M; Armitage CW; O'Meara CP; Beagley KW
    Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
    Poston TB; Darville T
    Curr Top Microbiol Immunol; 2018; 412():217-237. PubMed ID: 27033698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.
    Knight SC; Iqball S; Woods C; Stagg A; Ward ME; Tuffrey M
    Immunology; 1995 May; 85(1):8-15. PubMed ID: 7543450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for Chlamydia infections of the female genital tract.
    Hafner LM; McNeilly C
    Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
    Yu H; Karunakaran KP; Jiang X; Brunham RC
    Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects.
    Hafner LM; Timms P
    Expert Rev Vaccines; 2018 Jan; 17(1):57-69. PubMed ID: 29264970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
    Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
    Poston TB; Gottlieb SL; Darville T
    Vaccine; 2019 Nov; 37(50):7289-7294. PubMed ID: 28111145
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Chavda VP; Pandya A; Kypreos E; Patravale V; Apostolopoulos V
    Expert Rev Vaccines; 2022 Jun; 21(6):771-781. PubMed ID: 35470769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans.
    Wang J; Zhang Y; Lu C; Lei L; Yu P; Zhong G
    J Immunol; 2010 Aug; 185(3):1670-80. PubMed ID: 20581152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women.
    Agrawal T; Vats V; Salhan S; Mittal A
    J Reprod Immunol; 2009 Dec; 83(1-2):173-8. PubMed ID: 19896206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness.
    Eko FO; Talin BA; Lubitz W
    Hum Vaccin; 2008; 4(3):176-83. PubMed ID: 18382139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.
    Whittum-Hudson JA; An LL; Saltzman WM; Prendergast RA; MacDonald AB
    Nat Med; 1996 Oct; 2(10):1116-21. PubMed ID: 8837610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
    Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
    J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis.
    Porcella SF; Carlson JH; Sturdevant DE; Sturdevant GL; Kanakabandi K; Virtaneva K; Wilder H; Whitmire WM; Song L; Caldwell HD
    Infect Immun; 2015 Feb; 83(2):534-43. PubMed ID: 25404022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Chlamydia trachomatis Vaccinology.
    de la Maza LM; Zhong G; Brunham RC
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28228394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
    Rey-Ladino J; Ross AG; Cripps AW
    Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.